Transcend Medical

Menlo Park, United States Founded: 2006 • Age: 20 yrs Acquired By Alcon
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.

About Transcend Medical

Transcend Medical is a Technology company based in Menlo Park (United States) founded in 2006, and was acquired by Alcon in February 2016. Minimally invasive glaucoma stents are developed to enhance aqueous outflow. It operates in the Technology and Healthcare sectors. Transcend Medical has raised $122.27 million across 4 funding rounds from investors including Alcon, Canaan and Finistere Ventures. The company has 20 employees. The company was acqui-hired. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is TRANSCEND MEDICAL, INC. Its competitors include Glaukos, Myra Vision and Ivantis; 3 of its 3 listed competitors have raised funding.

Company details

Transcend Medical was founded in 2006 and is headquartered in Menlo Park, United States. Medical devices for minimally invasive glaucoma interventions are developed by the company within the ophthalmology sector. The CyPass Micro-Stent, implanted in the supraciliary space, is designed to reduce intraocular pressure by creating a micro-cyclodialysis that bypasses the ciliary body and targets the suprachoroidal outflow pathway, similar to prostaglandin analogues.

  • Headquarters Menlo Park, United States
  • Employees 20
  • Stage Acquired
  • Sectors
    Technology
    Healthcare
  • Website transcendmedical.com
  • Social LinkedIn X
  • Acquired by Alcon (Feb 2016)
  • Legal Name Transcend Medical, Inc
Key Metrics
  • Total Equity Funding
    $122.27M (USD)

    in 4 rounds

  • Latest Funding Round
    $29.27M (USD), Series C

    Jan 2015

  • Investors
    Alcon

    & 9 more

  • Employee Count
    20
  • Acquired by
    Alcon

    (Feb 2016)

Funding Insights of Transcend Medical

Transcend Medical has successfully raised a total of $122.27M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $29.27 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $122.27M
  • Total Rounds 4
  • Last Round Series C β€” $29.27M
  • First Round $7M

    (Nov 2006)

  • Investors Count 9

All 4 funding rounds of Transcend Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2015$29.27MSeries C––
–
Jul 2011$51MSeries B–Finistere Ventures, Kaiser Permanente Ventures
Jun 2009$35MSeries B–HLM Venture Partners
Nov 2006$7MSeries A––
Valuation history

10 investors in total: 10 institutional.

Investors in Transcend Medical

Transcend Medical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Alcon, Canaan and Finistere Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Canaan is recognized as an early-stage venture capital firm.
1987canaan.comSan Francisco, United States
finistere.com
VC firm investing in expansion stage tech and life sciences companies in the US
hlmvp.comWaltham, United States
Tech and Life Sciences focused corporate VC firm investing in the US
kpventures.comOakland, United States
Early-stage healthcare startups are supported with venture capital.
lvpcapital.comSan Ramon, United States
Venture capital and private equity investment firm
morgenthaler.comPortola Valley, United States
US venture capital investments are made across all stages.
splitrock.comEden Prairie, United States
Investments are made in US life sciences and energy companies.
technologypartners.comPalo Alto, United States
Corporate-backed venture capital firm focused on fintech, energy, and multiple sectors
investorgrowthcapital.comNew York, United States
Developer of a wide range of eye care products
1945alcon.comFort Worth, United States
Premium access

Investor details for Transcend Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Transcend Medical

4 dated milestones of Transcend Medical across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Transcend Medical is founded.
  2. Funding First funding round of $7.0M.
  3. Funding Latest funding round, Series C, of $29.3M.
  4. Exit Acquired by Alcon.

Competitors of Transcend Medical

Transcend Medical has 3 listed competitors in our database, 3 of them funded. They include Glaukos, Myra Vision and Ivantis.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
glaukos.com2001Laguna Hills, United States$117.57M907
Developer of implants to treat glaucoma
myravision.com2019Campbell, United States$42M
Nanotechnology-based devices for glaucoma treatment are developed.
ivantisinc.com2007Irvine, United States$166.23M132
Implantable device to relieve intraocular pressure in open angle glaucoma
Premium access

Detailed competitors of Transcend Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Sensors & Smart Devices

3 companies that operate in the same segment as Transcend Medical (Sensors & Smart Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart fitness equipment and streaming platforms are provided.
2011New York, New York, United StatesUSD 995.53 MUSD 2.45 B2,894
VR-based head-mounted displays for gaming are provided by Oculus.
2012Menlo Park, California, United StatesUSD 107.05 M
Cloud-based business telephony and home security services are provided.
2004Palo Alto, California, United StatesUSD 87.97 MUSD 273.6 M1,190
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Transcend Medical

Premium access

Complete news archive for Transcend Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Transcend Medical

Transcend Medical was founded in 2006.

Transcend Medical is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.

Transcend Medical is a funded company, having raised a total of $122.27M across 4 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on Nov 2006.

Transcend Medical has 20 employees.

Transcend Medical was founded in 2006 and is headquartered in Menlo Park, United States. Medical devices for minimally invasive glaucoma interventions are developed by the company within the ophthalmology sector. The CyPass Micro-Stent, implanted in the supraciliary space, is designed to reduce intraocular pressure by creating a micro-cyclodialysis that bypasses the ciliary body and targets the suprachoroidal outflow pathway, similar to prostaglandin analogues.

Transcend Medical's top competitors include Glaukos, Myra Vision and Ivantis.

Transcend Medical has 10 investors. Key investors include Alcon, Canaan, Finistere Ventures, HLM Venture Partners, and Kaiser Permanente Ventures.

Transcend Medical operates through Transcend Medical, Inc.

Yes. Transcend Medical was acquired by Alcon in February 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available